M Rylander

458 total citations
19 papers, 370 citations indexed

About

M Rylander is a scholar working on Pharmacology, Infectious Diseases and Clinical Biochemistry. According to data from OpenAlex, M Rylander has authored 19 papers receiving a total of 370 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pharmacology, 6 papers in Infectious Diseases and 6 papers in Clinical Biochemistry. Recurrent topics in M Rylander's work include Antibiotics Pharmacokinetics and Efficacy (7 papers), Bacterial Identification and Susceptibility Testing (6 papers) and Antibiotic Resistance in Bacteria (6 papers). M Rylander is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (7 papers), Bacterial Identification and Susceptibility Testing (6 papers) and Antibiotic Resistance in Bacteria (6 papers). M Rylander collaborates with scholars based in Sweden, Switzerland and Finland. M Rylander's co-authors include Gerd Faxelius, Baldvin Jónsson, Hans O. Hallander, S Ringertz, S. Ragnar Norrby, C. E. Nord, Per Montan, Ragnar Norrby, Ulrika Ransjö and Charlotta Edlund and has published in prestigious journals such as Journal of Clinical Microbiology, Antimicrobial Agents and Chemotherapy and Journal of Antimicrobial Chemotherapy.

In The Last Decade

M Rylander

19 papers receiving 359 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M Rylander Sweden 11 129 105 85 66 61 19 370
Mala Kumar India 10 90 0.7× 145 1.4× 47 0.6× 9 0.1× 67 1.1× 41 422
V. S. Randhawa India 11 35 0.3× 139 1.3× 16 0.2× 48 0.7× 101 1.7× 20 332
A. Scarcella Italy 12 54 0.4× 156 1.5× 47 0.6× 17 0.3× 141 2.3× 17 517
Caroline Blazejewski France 7 89 0.7× 80 0.8× 36 0.4× 69 1.0× 172 2.8× 8 392
K Murono Japan 13 63 0.5× 175 1.7× 30 0.4× 14 0.2× 115 1.9× 43 466
J. Richards United Kingdom 8 63 0.5× 135 1.3× 32 0.4× 32 0.5× 90 1.5× 13 422
Valeria Crivaro Italy 11 37 0.3× 118 1.1× 11 0.1× 20 0.3× 62 1.0× 13 498
Mohan Pammi Venkatesh United States 10 123 1.0× 137 1.3× 59 0.7× 41 0.6× 142 2.3× 11 468
P. Clarke Ireland 7 62 0.5× 54 0.5× 52 0.6× 61 0.9× 190 3.1× 8 322
P. Schacht Germany 9 52 0.4× 174 1.7× 43 0.5× 44 0.7× 47 0.8× 15 550

Countries citing papers authored by M Rylander

Since Specialization
Citations

This map shows the geographic impact of M Rylander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Rylander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Rylander more than expected).

Fields of papers citing papers by M Rylander

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Rylander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Rylander. The network helps show where M Rylander may publish in the future.

Co-authorship network of co-authors of M Rylander

This figure shows the co-authorship network connecting the top 25 collaborators of M Rylander. A scholar is included among the top collaborators of M Rylander based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Rylander. M Rylander is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Farra, Anna, et al.. (2003). Different trends in antibiotic resistance rates at a university teaching hospital. Clinical Microbiology and Infection. 9(5). 388–396. 16 indexed citations
2.
Montan, Per, et al.. (2000). Preoperative Gentamicin Eye Drops and Chlorhexidine Solution in Cataract Surgery. Experimental and Clinical Results. European Journal of Ophthalmology. 10(4). 286–292. 25 indexed citations
3.
Hanberger, Håkan, Lennart E. Nilsson, Berndt E. B. Claesson, et al.. (1999). New species-related MIC breakpoints for early detection of development of resistance among Gram-negative bacteria in Swedish intensive care units. Journal of Antimicrobial Chemotherapy. 44(5). 611–619. 15 indexed citations
4.
Rylander, M. (1999). Trovafloxacin Susceptibility of Aerobic Clinical Bacterial Isolates from Sweden. Scandinavian Journal of Infectious Diseases. 31(6). 567–572. 1 indexed citations
5.
Jónsson, Baldvin, M Rylander, & Gerd Faxelius. (1998). Ureaplasma urealyticum, erythromycin and respiratory morbidity in high-risk preterm neonates. Acta Paediatrica. 87(10). 1079–1084. 60 indexed citations
6.
Jónsson, Baldvin, M Rylander, & Gerd Faxelius. (1998). Ureaplasma urealyticum, erythromycin and respiratory morbidity in high‐risk preterm neonates. Acta Paediatrica. 87(10). 1079–1084. 54 indexed citations
7.
Rylander, M, J. Rollof, Karin Jacobsson, & S. Ragnar Norrby. (1995). Comparative antibacterial activity of L-695,256, a carbapenem active against methicillin-resistant staphylococci. Antimicrobial Agents and Chemotherapy. 39(5). 1178–1181. 4 indexed citations
8.
Jónsson, Baldvin, et al.. (1994). Neonatal Ureaplasma urealyticum colonization and chronic lung disease. Acta Paediatrica. 83(9). 927–930. 36 indexed citations
9.
Bygdeman, S, Peter Lidbrink, Bengt Gästrin, et al.. (1993). Antibiotic Susceptibility, Serovars and Auxotypes of Gonococcal Isolates in Stockholm. Relation to Geographical Origin of the Infection. International Journal of STD & AIDS. 4(1). 33–40. 9 indexed citations
10.
Hedberg, M., Charlotta Edlund, L Lindqvist, M Rylander, & C. E. Nord. (1992). Purification and characterization of an imipenem hydrolysing metallo-β-lactamase from Bacteroides fragilis. Journal of Antimicrobial Chemotherapy. 29(2). 105–113. 26 indexed citations
11.
Carlos, Celia, S Ringertz, M Rylander, Pentti Huovinen, & Gerd Faxelius. (1991). Nosocomial Staphylococcus epidermidis septicaemia among very low birth weight neonates in an intensive care unit. Journal of Hospital Infection. 19(3). 201–207. 20 indexed citations
12.
Nord, C. E., M Rylander, & S. Ragnar Norrby. (1991). Susceptibility of anaerobic bacteria to BAY v 3522. Antimicrobial Agents and Chemotherapy. 35(3). 594–599. 4 indexed citations
13.
Ringertz, S, et al.. (1991). Disk diffusion method for susceptibility testing of Neisseria gonorrhoeae. Journal of Clinical Microbiology. 29(8). 1604–1609. 19 indexed citations
14.
Rylander, M, C. E. Nord, & S. Ragnar Norrby. (1990). Comparative in vitro activity of the new oral cephalosporin bay v 3522 against aerobic and anaerobic bacteria. European Journal of Clinical Microbiology & Infectious Diseases. 9(10). 777–782. 5 indexed citations
15.
Rylander, M, C. E. Nord, & S. Ragnar Norrby. (1989). Comparative in vitro activity of the new oral penem ALP-201 against aerobic and anaerobic bacteria. European Journal of Clinical Microbiology & Infectious Diseases. 8(10). 919–924. 8 indexed citations
16.
Rylander, M & Hans O. Hallander. (1988). In vitro comparison of the activity of doxycycline, tetracycline, erythromycin and a new macrolide, CP 62993, against Mycoplasma pneumoniae, Mycoplasma hominis and Ureaplasma urealyticum.. PubMed. 53. 12–7. 41 indexed citations
17.
Rylander, M & S. Ragnar Norrby. (1983). Norfloxacin penetration into subcutaneous tissue cage fluid in rabbits and efficacy in vivo. Antimicrobial Agents and Chemotherapy. 23(3). 352–355. 8 indexed citations
18.
Rylander, M, et al.. (1978). Studies on the pharmacokinetics of cefoxitin, cefuroxime, cephaloridine and cephalothin using subcutaneous tissue cages.. PubMed. 52–7. 18 indexed citations
19.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mala Kumar Breakdown of academic impact, for papers by V. S. Randhawa Breakdown of academic impact, for papers by A. Scarcella Breakdown of academic impact, for papers by Caroline Blazejewski Breakdown of academic impact, for papers by K Murono Breakdown of academic impact, for papers by J. Richards Breakdown of academic impact, for papers by Valeria Crivaro Breakdown of academic impact, for papers by Mohan Pammi Venkatesh Breakdown of academic impact, for papers by P. Clarke Breakdown of academic impact, for papers by P. Schacht
Rankless by CCL
2026